Who founded Hemanext?

Hemanext was founded by Martin Cannon.

How much funding has Hemanext raised?

Hemanext has disclosed $122.3M raised across 8 of its 10 known rounds.

Where is Hemanext headquartered?

Hemanext is headquartered in Lexington, US.

Hemanext

Lexington, US · Delaware corporation · 5 known investors

Find your way into Hemanext

583 people in our graph share verified history with the Hemanext team — schools, employers, funds. One of them is your warm intro.

Danielle Abdelahadunlockedknows Daan Kok · together at Bluebird Bio (overlapped)

knows the team · via Wittenberg University

×10knows the team · via Kearney

Hemanext develops oxygen-controlled storage technology to preserve red blood cell quality and function during transfusion storage. The company serves hospitals and blood establishments seeking to improve patient outcomes in transfusion medicine.

Biotech Healthtech Medical Devices

Founders & leadership

Martin Cannon Founder and former CEOMartin Cannon held senior positions at Bain & Company and A.T. Kearney focused on healthcare and transfusion medicine before founding Hemanext, which develops oxygen-controlled storage technology for preserving red blood cells during transfusion.

Jill Buckley Vice President Human Resources2019–2025Jill Buckley is Vice President of Human Resources at Hemanext, bringing experience in HR leadership across startups and larger organizations in multiple industries.

Daan Kok Head of BD and Strategy2024–2026Daan Kok holds a master's degree in International Business Studies and a chartered management accountant credential. He brings extensive experience in biotech and medtech across finance, sales, marketing, regulatory, and general management roles in Europe and the United States, including founding a consulting company.

Robert Haime Vice President of Commercial Operations2023–2025Robert Haime holds an Industrial Engineering background and brings over 25 years of experience in blood banking, transfusion medicine, and medical devices, including roles in manufacturing, product management, and commercial leadership. He previously commercialized the Acrodose Platelet System and scaled manufacturing operations for healthcare technology platforms.

Rafael Cordero VP of Product Development2014–2017Rafael Cordero held product development and design roles at medical device companies including Aspect Medical, where he worked on monitoring systems, and at Innovasea in aquaculture technology. He is Vice President of Product Development at Hemanext, which develops oxygen-controlled storage systems for red blood cell preservation.

Michael BavoneseExecutive

Andrew DunhamNamed on SEC filing

Board

Stephen EckertChairman of the Board of Directors

Philip PeadBoard director

Geoffrey CrouseBoard director

William Patrick O'NeillBoard director

Eduardo AvayuBoard director

Investors · 5

Also in the syndicate · 5

Antaeus Enterprises, Inc.Grabe Family OfficeOmega Family OfficeThe Eduardo Avayu Family OfficeThe Testa Family Office

Funding

SEC filings, press & company announcements

$122.3M disclosed across 8 of 10 rounds · 2016–2025

Undisclosed amountSeries ASep 2021
Antaeus Enterprises, Inc., Grabe Family Office, Omega Family Office, The Eduardo Avayu Family Office, The Testa Family Office
Source ↗

▶$20MraisedAug 2025 · 29 investors · Other Health Care

Rule 506(b)